Analytical use of cookies
CVE-2022-50506: linux kernel vulnerability
CVE-2022-50506: medium vulnerability affecting linux kernel. Check CVSS, KEV status, business impact and recommended administrator actions.
- CVSS
- 5.5 MEDIUM
- EPSS
- 3.46%
- Known exploited
- not in KEV
- Product
- linux kernel
What is known
In the Linux kernel, the following vulnerability has been resolved: drbd: only clone bio if we have a backing device Commit c347a787e34cb (drbd: set ->bi_bdev in drbd_req_new) moved a bio_set_dev call (which has since been removed) to "earlier", from drbd_request_prepare to drbd_req_new. The problem is that this accesses device->ldev->backing_bdev, which is not NULL-checked at this point. When we don't have an ldev (i.e. when the DRBD device is diskless), this leads to a null pointer deref. So, only allocate the private_bio if we actually have a disk. This is also a small optimization, since we don't clone the bio to only to immediately free it again in the diskless case.
Business impact
Successful exploitation of CVE-2022-50506, a medium vulnerability (CVSS 5.5) affecting linux kernel, may affect the confidentiality, integrity or availability of the vulnerable environment. The exact impact depends on the installed version, exposed interfaces and deployment configuration.
Recommended administrator action
Confirm whether linux kernel is present and compare installed versions with the vendor advisory and NVD record. Apply the vendor patch or documented mitigation; until remediation is complete, reduce exposure of affected interfaces, review relevant logs and monitor for indicators of exploitation. DataHouse can support version verification, managed patching, network exposure reduction, log review and backup validation for dedicated, cloud and colocated environments.